serum amyloid A1
Última atualização 8 Sept 2025
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
The SAA1 gene provides instructions for making a protein called serum amyloid A1. This protein is made primarily in the liver and circulates in low levels in the blood. Although its function is not fully understood, serum amyloid A1 appears to play a role in the immune system. Serum amyloid A1 may help repair damaged tissues, act as an antibacterial agent, and signal the migration of germ-fighting cells to sites of infection.
Escolhas de vídeos para GenesBiblioteca de vídeos
Normal function
The SAA1 gene provides instructions for making a protein called serum amyloid A1. This protein is made primarily in the liver and circulates in low levels in the blood. Although its function is not fully understood, serum amyloid A1 appears to play a role in the immune system. Serum amyloid A1 may help repair damaged tissues, act as an antibacterial agent, and signal the migration of germ-fighting cells to sites of infection.
Levels of this protein increase in the blood and other tissues under conditions of inflammation. Inflammation occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair. When this has been accomplished, the body stops the inflammatory response to prevent damage to its own cells and tissues.
There are three versions of the serum amyloid A1 protein, known as alpha, beta, and gamma, which differ by one or two protein building blocks (amino acids). The frequency of these versions differs across populations. In white populations, for example, the alpha version predominates and gamma is rare. In the Japanese population, however, the three versions appear almost equally.
Conditions referring to this gene or chromosome
Other names
PIG4
SAA
SAA_HUMAN
TP53I4
tumour protein p53 inducible protein 4
Related patient information and medicines

Patient information leaflet
Fraqueza muscular
The condition usually goes away after a few years but can become more progressive in some people. Amiloidose involves deposits of an anormalidades protein called amyloid throughout the body, including muscles and kidneys. The amyloid damages the organs it attacks, including muscles. Other rare causes : Direct damage to muscles can occur i... Examples.

Patient information leaflet
Mieloma
Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Bone marrow is the spongy tissue at the centre of some bones that produces the body's blood cells. If you dev... Amyloidosis This is an uncommon complication of myeloma. This is a condition where abnormal protein (amyloid) accumulates in various parts of the body. It.

Patient information leaflet
Macrocitose e anemia macrocítica
Macrocytosis refers para red blood cells which are larger than normal. It does not cause any symptoms in itself. Se... An increase in the number of immature red blood cells called reticulocytes (reticulocytosis). Other blood disorders including myeloid leukaemia Leukaemia , aplastic anaemia (a condition affecting the bone marrow) and some other rare.

Patient information leaflet
Medicação e tratamento para demência
A tranquilliser or an antipsychotic medicine Antipsychotic medicines is sometimes pr... Research continues looking for new medicines to help with dementia and there is some promising research with drugs known as 'mabs' which are a form of immunotherapy. They target amyloid no brain, which is part of the disease process that causes dementia,.

Patient information leaflet
Leucemias infantis
Leukaemia is a cancer of the cells which develop into blood cells. There are different types of leukaemia. Some will have acute myeloid leukaemia. Este leaflet gives a general overview of childhood leukaemias. The remaining clear fluid is called serum. 'Myeloid' means that an abnormal cancerous cell é a cell that originated from a myeloid stem.

Patient information leaflet
Triagem para síndrome de Down
There are two different types of tests that can be done to look for síndrome de Down during pregnancy - a screening test and a diagnostic test. What Down's syndrome screening tests are available? 10-14 weeks - combined test The standard test for Down's syndrome includes a combination of a nuchal translucency scan ( also called the NT scan - more.
Leitura adicional e referências
- serum amyloid A1; MedlinePlus, National Library of Medicine.
- Bakkaloglu A, Duzova A, Ozen S, Balci B, Besbas N, Topaloglu R, Ozaltin F, Yilmaz E. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population. J Rheumatol. 2004 Jun;31(6):1139-42.
- Ben-Chetrit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis--phenotype-genotype correlation, treatment and prognosis. J Nephrol. 2003 May-Jun;16(3):431-4.
- Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid. 1998 Dec;5(4):262-5. doi: 10.3109/13506129809007299.
- Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet. 2000 Nov;67(5):1136-43. doi: 10.1016/S0002-9297(07)62944-9. Epub 2000 Oct 3.
- Delibas A, Oner A, Balci B, Demircin G, Bulbul M, Bek K, Erdogan O, Baysun S, Yilmaz E. Genetic risk factors of amyloidogenesis in familial Mediterranean fever. Am J Nephrol. 2005 Sep-Oct;25(5):434-40. doi: 10.1159/000087824. Epub 2005 Aug 23.
- Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum. 2003 Apr;48(4):1149-55. doi: 10.1002/art.10944.
- Kelkitli E, Bilgici B, Tokgoz B, Dilek M, Bedir A, Akpolat I, Utas C, Akpolat T. SAA1 alpha/alpha alleles in amyloidosis. J Nephrol. 2006 Mar-Apr;19(2):189-91.
- Medlej-Hashim M, Delague V, Chouery E, Salem N, Rawashdeh M, Lefranc G, Loiselet J, Megarbane A. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet. 2004 Feb 10;5:4. doi: 10.1186/1471-2350-5-4.
- Moriguchi M, Kaneko H, Terai C, Koseki Y, Kajiyama H, Inada S, Kitamura Y, Kamatani N. Relative transcriptional activities of SAA1 promoters polymorphic at position -13(T/C): potential association between increased transcription and amyloidosis. Amyloid. 2005 Mar;12(1):26-32. doi: 10.1080/13506120500032394.
- Ray A, Shakya A, Kumar D, Benson MD, Ray BK. Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis. J Immunol. 2006 Aug 15;177(4):2601-9. doi: 10.4049/jimmunol.177.4.2601.
- Stevens FJ. Hypothetical structure of human serum amyloid A protein. Amyloid. 2004 Jun;11(2):71-80. doi: 10.1080/13506120412331272296.
- Thorn CF, Lu ZY, Whitehead AS. Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells. Eur J Immunol. 2003 Sep;33(9):2630-9. doi: 10.1002/eji.200323985.
- Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med. 1999 Apr;37(4):381-8. doi: 10.1515/CCLM.1999.063.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

